Bionano Genomics (BNGO) Short-term Investments (2021 - 2026)

Bionano Genomics has disclosed Short-term Investments across 6 years of filings, most recently posting $11.0 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $11.0 million, down 24.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.0 million (down 24.83% YoY), and the FY2025 annual result was $16.3 million, up 5290.4% from the prior year.
• Short-term Investments came in at $11.0 million for Q1 2026 at Bionano Genomics, down from $16.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $192.4 million in Q1 2022 to a low of $302000.0 in Q4 2024.
• The 5-year median for Short-term Investments is $15.4 million (2025), against an average of $51.3 million.
• Across the five-year window, Short-term Investments slumped 99.14% in 2024 and surged 5290.4% in 2025, its largest moves.
• Bionano Genomics' Short-term Investments stood at $152.0 million in 2022, then plunged by 76.9% to $35.1 million in 2023, then plunged by 99.14% to $302000.0 in 2024, then soared by 5290.4% to $16.3 million in 2025, then slumped by 32.55% to $11.0 million in 2026.
• The last three Short-term Investments figures came in at $11.0 million (Q1 2026), $16.3 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.